Showing results (121-130 of 267) with videos related to
Sort By:
Pageof 27
Respiratory Medicine|January 18, 2015
One-year outcomes of inhaled controller therapies added to systemic corticosteroids after asthma-related hospital dischargeMohsen Sadatsafavi, Larry D Lynd, Mary A De Vera, et al.Respiratory Research|May 2, 2023
Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trialsWenjia Chen, Helen K Reddel, J Mark FitzGerald, et al.The Journal of Antimicrobial Chemotherapy|May 22, 2021
Impact of the 13-valent pneumococcal conjugate vaccine on acute otitis media and acute sinusitis epidemiology in British Columbia, CanadaNirma Khatri Vadlamudi, Ariana Saatchi, David M Patrick, et al.International Journal of Chronic Obstructive Pulmonary Disease|April 1, 2021
Are COPD Prescription Patterns Aligned with Guidelines? Evidence from a Canadian Population-Based StudyTaraneh Bahremand, Mahyar Etminan, Nardin Roshan-Moniri, et al.BMJ Open|September 6, 2013
Complementary and alternative asthma treatments and their association with asthma control: a population-based studyWenjia Chen, J Mark Fitzgerald, Roxanne Rousseau, et al.Canadian Family Physician Medecin De Famille Canadien|June 14, 2023
Risk and distribution of chronic obstructive pulmonary disease-related hospitalizations among primary care patientsScott Garrison, Hamid Tavakoli, Mohsen Sadatsafavi, et al.Eclinicalmedicine|July 28, 2022
ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT)Abdollah Safari, Amin Adibi, Don D Sin, et al.Thorax|January 7, 2016
The natural history of severe asthma and influences of early risk factors: a population-based cohort studyWenjia Chen, Carlo A Marra, Larry D Lynd, et al.The Lancet. Digital Health|August 28, 2021
Personalising add-on treatment with inhaled corticosteroids in patients with chronic obstructive pulmonary disease: a benefit-harm modelling studyHenock G Yebyo, Julia Braun, Dominik Menges, et al.The European Respiratory Journal|August 29, 2020
Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?Mohsen Sadatsafavi, James McCormack, John Petkau, et al.Pageof 27